Blocked Primer Isothermal Amplification for Rapid TB Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic tests for Mycobacterium tuberculosis, particularly for detecting multi-drug resistant strains, face challenges with low sensitivity and long turnaround times, leading to delayed treatment and increased morbidity and transmission.
Innovation Solution
An isothermal nucleic acid sequence amplification method using blocked primers and thermostable RNase H2 enzyme, which allows for rapid and specific detection of rpoB gene mutations conferring rifampin resistance, employing helicase-dependent amplification and chip-based detection for visualizing attomole quantities of nucleic acids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If sputum microscopy is used for diagnosis, then the method is simple and inexpensive, but the sensitivity is poor
Solution Approach 1:
The patent applies preliminary action by performing isothermal amplification of nucleic acids before detection. The blocked primers are pre-designed with ribonucleotide flaps that will be cleaved by RNase H2 during the amplification process, enabling sensitive detection of M. tuberculosis DNA/RNA in clinical samples before the actual diagnostic readout occurs.
Solution Approach 2:
The patent uses an intermediary approach by introducing blocked primers with ribonucleotide flaps as mediators between the target nucleic acid and the detection system. These primers require cleavage by RNase H2 to become functional, creating a two-step mechanism that enhances specificity and sensitivity while maintaining operational simplicity.
2Reliability
If mycobacterium culture is used for diagnosis, then the sensitivity is much more sensitive, but the turnaround time is very slow (2-8 weeks) and the technical complexity is high
Solution Approach 1:
The patent replaces the mechanical/biological culture system with a nucleic acid amplification system. Instead of waiting for mycobacteria to grow in culture media over weeks, the method directly amplifies and detects bacterial nucleic acids using isothermal amplification with blocked primers and RNase H2, reducing turnaround time to hours or minutes while maintaining high sensitivity.
Solution Approach 2:
The method performs preliminary extraction and amplification of nucleic acids from clinical samples, bypassing the need for lengthy culture growth. The blocked primer amplification system is designed to work directly with extracted nucleic acids, enabling rapid detection without the time-consuming culture step.
3Ease of operation
If real-time PCR approach is used, then the ease-of-use is improved, but the cost is high
Solution Approach 1:
The patent changes the temperature parameter from cyclic PCR temperature changes to constant isothermal temperature. The amplification reaction is performed at a single temperature (50-65°C) rather than cycling through multiple temperatures, simplifying the instrumentation requirements and reducing costs while maintaining ease of operation.
Solution Approach 2:
The patent introduces RNase H2 as an intermediary enzyme that cleaves the ribonucleotide flaps from blocked primers during isothermal amplification. This enzymatic mechanism enables specific primer activation and amplification without requiring complex thermal cycling equipment, reducing costs while maintaining operational simplicity similar to real-time PCR.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables rapid detection of rifampin-resistant TB strains within 30 minutes, improving sensitivity and specificity, and can be used in point-of-care settings, reducing treatment delays and transmission risks.
Implementation Method 1
the RNase H enzyme removes the flap from the blocked primer resulting in an unblocked primer
Implementation Method 2
the helicase-dependent amplification reagents extend the unblocked primer to produce a double stranded amplicon
Implementation Method 3
heating the mixture of step (b), wherein the RNase H enzyme removes the flap from the blocked primer resulting in an unblocked primer, and the helicase-dependent amplification reagents extend the unblocked primer to produce a double stranded amplicon which is denatured into a single stranded nucleic acid amplicon
Data Source
AI summary
Methods for rapidly detecting clinically relevant mutations in the infectious genome of an agent are disclosed. The methods include use of a novel target and temperature dependent RNase H mediated cleavage of blocked DNA primers to initiate isothermal helicase-dependent amplification of a target sequence such as a sequence in the the rpoB gene.